Table 3 Hazard ratios (HR) with their confidence intervals, and p-values in the CS and FG results.

From: Comparing predictions among competing risks models with rare events: application to KNOW-CKD study—a multicentre cohort study of chronic kidney disease

Covariate

CS method

FG method

HR (95% CI)

p-value

HR (95% CI)

p-value

Age\(^2\)

1.04 (1.02, 1.07)

0.002

1.05 (1.02, 1.07)

\({\varvec{<}}.{\textbf {001}}\)

Gender (ref.male)

0.44 (0.20, 0.97)

0.041

0.48 (0.22, 1.03)

0.061

CAD

1.34 (0.71, 2.55)

0.373

1.38 (0.72, 2.63)

0.330

DM

2.15 (1.28, 3.60)

0.004

2.11 (1.21, 3.66)

0.008

CVD

3.15 (1.73, 5.72)

\({\varvec{<}}.{\textbf {001}}\)

3.03 (1.68, 5.48)

\({\varvec{<}}.{\textbf {001}}\)

Smoking

0.98 (0.54, 1.77)

0.947

1.00 (0.55, 1.83)

1.000

CKD_stage

1.03 (0.83, 1.28)

0.766

0.95 (0.75, 1.19)

0.630

BMI

0.95 (0.88, 1.03)

0.195

0.95 (0.89, 1.02)

0.160

HG

0.95 (0.82, 1.11)

0.511

0.99 (0.82, 1.02)

0.920

CRP

1.01 (0.98, 1.04)

0.700

1.01 (0.98, 1.04)

0.540

LDL

1.00 (1.00, 1.01)

0.589

1.00 (0.99, 1.01)

0.770

MAP

1.00 (0.98, 1.02)

0.946

1.00 (0.98, 1.02)

0.670

  1. * The bold numbers represent statistically significant with 5% significance. The age is included as a square term. CAD: baseline coronary artery disease; DM: baseline diabetes mellitus; CVD: baseline cardiovascular disease; BMI: body mass index; HG: baseline hemoglobin; CRP: baseline high sensitivity C-reactive protein; MAP: baseline mean arterial pressure; LDL: baseline low-density lipoprotein cholesterol.
Back to article page